<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39090126</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Sequence-specific nanoparticle barcode strategy for multiplex human enterovirus typing.</ArticleTitle><Pagination><StartPage>6478</StartPage><MedlinePgn>6478</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6478</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-024-50921-w</ELocationID><Abstract><AbstractText>Human enteroviruses (HEV) can cause a range of diseases from mild to potentially life-threatening. Identification and genotyping of HEV are crucial for disease management. Existing typing methods, however, have inherent limitations. Developing alternative methods to detect HEV with more virus types, high accuracy, and sensitivity in an accessible manner presents a technological and analytical challenge. Here, a sequence-specific nanoparticle barcode (SSNB) method is presented for simultaneous detection of 10 HEV types. This method significantly increases sensitivity, enhancing detection by 10-10<sup>6</sup> times over the traditional multiplex hybrid genotyping (MHG) method, by resolving cross-interference between the multiple primer sets. Furthermore, the SSNB method demonstrates a 100% specificity in accurately distinguishing between 10 different HEV types and other prevalent clinical viruses. In an analysis of 70 clinical throat swab samples, the SSNB method shows slightly higher detection rate for positive samples (50%) compared to the RT-PCR method (48.6%). Additionally, further assessment of the typing accuracy for samples identified as positive by SSNB using sequencing method reveals a concordance rate of 100%. The combined high sensitivity and specificity level of the methodology, together with the capability for multiple type analysis and compatibility with clinical workflow, make this approach a promising tool for clinical settings.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhong</LastName><ForeName>Zecheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Vaccines for Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Su</LastName><ForeName>Xiaosong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Zhongshan Hospital Fudan University Xiamen Branch, Xiamen, 361015, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yang</LastName><ForeName>Kunyu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Vaccines for Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Weida</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Vaccines for Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Vaccines for Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhuo</LastName><ForeName>Zhihao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Vaccines for Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Jiyu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Vaccines for Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Lesi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Vaccines for Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Sciences, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Shuizhen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Xiamen Haicang Hospital, Haiyu Road, Xiamen, 361026, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tingdong</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0685-2549</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Vaccines for Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, National Innovation Platform for Industry-Education Integration in Vaccine Research, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6601-9180</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Vaccines for Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, National Innovation Platform for Industry-Education Integration in Vaccine Research, Xiamen University, Xiamen, 361102, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Shengxiang</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7165-3004</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Vaccines for Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China. sxge@xmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China. sxge@xmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China. sxge@xmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, National Innovation Platform for Industry-Education Integration in Vaccine Research, Xiamen University, Xiamen, 361102, Fujian, China. sxge@xmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shiyin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8291-7290</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Vaccines for Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China. zhangshiyin@xmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China. zhangshiyin@xmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China. zhangshiyin@xmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, National Innovation Platform for Industry-Education Integration in Vaccine Research, Xiamen University, Xiamen, 361102, Fujian, China. zhangshiyin@xmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Ningshao</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-0179-5266</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Vaccines for Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China. nsxia@xmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China. nsxia@xmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China. nsxia@xmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Sciences, Xiamen University, Xiamen, 361102, Fujian, China. nsxia@xmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, National Innovation Platform for Industry-Education Integration in Vaccine Research, Xiamen University, Xiamen, 361102, Fujian, China. nsxia@xmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053758" MajorTopicYN="Y">Nanoparticles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058893" MajorTopicYN="N">DNA Barcoding, Taxonomic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060005" MajorTopicYN="N">Genotyping Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>0</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>0</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>1</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39090126</ArticleId><ArticleId IdType="pmc">PMC11294541</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-50921-w</ArticleId><ArticleId IdType="pii">10.1038/s41467-024-50921-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang, K. et al. Serotype specific epitopes identified by neutralizing antibodies underpin immunogenic differences in Enterovirus B. Nat. Commun.11, 4419 (2020). 10.1038/s41467-020-18250-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18250-w</ArticleId><ArticleId IdType="pmc">PMC7474084</ArticleId><ArticleId IdType="pubmed">32887892</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair, W. &amp; Omar, M. Enterovirus (StatPearls. Press, Treasure Island, 2023).</Citation></Reference><Reference><Citation>Guo, H. et al. A second open reading frame in human enterovirus determines viral replication in intestinal epithelial cells. Nat. Commun.10, 4066 (2019). 10.1038/s41467-019-12040-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12040-9</ArticleId><ArticleId IdType="pmc">PMC6731315</ArticleId><ArticleId IdType="pubmed">31492846</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, L. et al. Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations. BMC Med.13, 226 (2015). 10.1186/s12916-015-0448-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-015-0448-7</ArticleId><ArticleId IdType="pmc">PMC4574357</ArticleId><ArticleId IdType="pubmed">26381232</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, J. T. et al. Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis. PLoS Med.13, e1001975 (2016). 10.1371/journal.pmed.1001975</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001975</ArticleId><ArticleId IdType="pmc">PMC4792415</ArticleId><ArticleId IdType="pubmed">26978565</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing, W. et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect. Dis.14, 308–318 (2014). 10.1016/S1473-3099(13)70342-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Waghmare, A. et al. Clinical disease due to enterovirus D68 in adult hematologic malignancy patients and hematopoietic cell transplant recipients. Blood125, 1724–1729 (2015). 10.1182/blood-2014-12-616516</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2014-12-616516</ArticleId><ArticleId IdType="pmc">PMC4357580</ArticleId><ArticleId IdType="pubmed">25593338</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoester, M. et al. Upsurge of Enterovirus D68, the Netherlands, 2016. Emerg. Infect. Dis.23, 140–143 (2017). 10.3201/eid2301.161313</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2301.161313</ArticleId><ArticleId IdType="pmc">PMC5176244</ArticleId><ArticleId IdType="pubmed">27660916</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyrdak, R. et al. Outbreak of enterovirus D68 of the new B3 lineage in Stockholm, Sweden, August to September 2016. Euro Surveill21, 10.2807/1560-7917.ES.2016.21.46.30403 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5144949</ArticleId><ArticleId IdType="pubmed">27918255</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnick, J. L., Schmidt, N. J., Hampil, B. &amp; Ho, H. H. Lyophilized combination pools of enterovirus equine antisera: preparation and test procedures for the identification of field strains of 19 group A coxsackievirus serotypes. Intervirology8, 172–181 (1977). 10.1159/000148892</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000148892</ArticleId><ArticleId IdType="pubmed">558177</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, K. et al. Antigenic characteristics and genomic analysis of novel EV-A90 enteroviruses isolated in Xinjiang, China. Sci. Rep.8, 10247 (2018). 10.1038/s41598-018-28469-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-28469-9</ArticleId><ArticleId IdType="pmc">PMC6035207</ArticleId><ArticleId IdType="pubmed">29980696</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao, X. L. et al. Simultaneous detection of human enterovirus 71 and coxsackievirus A16 in clinical specimens by multiplex real-time PCR with an internal amplification control. Arch. Virol.154, 121–125 (2009). 10.1007/s00705-008-0266-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-008-0266-8</ArticleId><ArticleId IdType="pubmed">19057836</ArticleId></ArticleIdList></Reference><Reference><Citation>Beuret, C. Simultaneous detection of enteric viruses by multiplex real-time RT-PCR. J. Virol. Methods115, 1–8 (2004). 10.1016/j.jviromet.2003.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2003.09.005</ArticleId><ArticleId IdType="pubmed">14656455</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandolf, R., Ameis, D., Kirschner, P., Canu, A. &amp; Hofschneider, P. H. In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc. Natl Acad. Sci. USA84, 6272–6276 (1987). 10.1073/pnas.84.17.6272</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.84.17.6272</ArticleId><ArticleId IdType="pmc">PMC299053</ArticleId><ArticleId IdType="pubmed">2819870</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotbart, H. A. Nucleic acid detection systems for enteroviruses. Clin. Microbiol. Rev.4, 156–168 (1991). 10.1128/CMR.4.2.156</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.4.2.156</ArticleId><ArticleId IdType="pmc">PMC358188</ArticleId><ArticleId IdType="pubmed">1649002</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala, H. et al. Recommendations for enterovirus diagnostics and characterisation within and beyond Europe. J. Clin. Virol.101, 11–17 (2018). 10.1016/j.jcv.2018.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.01.008</ArticleId><ArticleId IdType="pubmed">29414181</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson, G. P., Kowtha, V. A. &amp; Taitt, C. R. Detection of fumonisin b1 and ochratoxin a in grain products using microsphere-based fluid array immunoassays. Toxins2, 297–309 (2010). 10.3390/toxins2020297</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins2020297</ArticleId><ArticleId IdType="pmc">PMC3202808</ArticleId><ArticleId IdType="pubmed">22069585</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamza, I. A., Jurzik, L. &amp; Wilhelm, M. Development of a Luminex assay for the simultaneous detection of human enteric viruses in sewage and river water. J. Virol. Methods204, 65–72 (2014). 10.1016/j.jviromet.2014.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2014.04.002</ArticleId><ArticleId IdType="pubmed">24747587</ArticleId></ArticleIdList></Reference><Reference><Citation>Monpoeho, S. et al. Quantification of enterovirus RNA in sludge samples using single tube real-time RT-PCR. Biotechniques29, 88–93 (2000). 10.2144/00291st03</Citation><ArticleIdList><ArticleId IdType="doi">10.2144/00291st03</ArticleId><ArticleId IdType="pubmed">10907082</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotani, O. et al. Neuropathogenicity of Two Saffold Virus Type 3 Isolates in Mouse Models. PLoS One11, e0148184 (2016). 10.1371/journal.pone.0148184</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0148184</ArticleId><ArticleId IdType="pmc">PMC4734772</ArticleId><ArticleId IdType="pubmed">26828718</ArticleId></ArticleIdList></Reference><Reference><Citation>Good, C., Wells, A. I. &amp; Coyne, C. B. Type III interferon signaling restricts enterovirus 71 infection of goblet cells. Sci. Adv.5, eaau4255 (2019). 10.1126/sciadv.aau4255</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aau4255</ArticleId><ArticleId IdType="pmc">PMC6402847</ArticleId><ArticleId IdType="pubmed">30854425</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon, T. et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis.10, 778–790 (2010). 10.1016/S1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuffenecker, I. et al. Epidemiological and clinical characteristics of patients infected with enterovirus D68, France, July to December 2014. Euro Surveill.21, 10.2807/1560-7917.ES.2016.21.19.30226 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27195770</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas-Alba, D. et al. Outbreak of brainstem encephalitis associated with enterovirus-A71 in Catalonia, Spain (2016): a clinical observational study in a children’s reference centre in Catalonia. Clin. Microbiol. Infect.23, 874–881 (2017). 10.1016/j.cmi.2017.03.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2017.03.016</ArticleId><ArticleId IdType="pubmed">28344164</ArticleId></ArticleIdList></Reference><Reference><Citation>Saarinen, N. V. V. et al. Multiplexed High-Throughput Serological Assay for Human Enteroviruses. Microorganisms8, 10.3390/microorganisms8060963 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7355947</ArticleId><ArticleId IdType="pubmed">32604930</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory, J. B., Litaker, R. W. &amp; Noble, R. T. Rapid one-step quantitative reverse transcriptase PCR assay with competitive internal positive control for detection of enteroviruses in environmental samples. Appl. Environ. Microbiol.72, 3960–3967 (2006). 10.1128/AEM.02291-05</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.02291-05</ArticleId><ArticleId IdType="pmc">PMC1489662</ArticleId><ArticleId IdType="pubmed">16751503</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman, N. M., Tracy, S., Gauntt, C. J. &amp; Fortmueller, U. Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridization. J. Clin. Microbiol.28, 843–850 (1990). 10.1128/jcm.28.5.843-850.1990</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.28.5.843-850.1990</ArticleId><ArticleId IdType="pmc">PMC267821</ArticleId><ArticleId IdType="pubmed">2161866</ArticleId></ArticleIdList></Reference><Reference><Citation>Joffret, M. L. et al. Whole Genome Sequencing of Enteroviruses Species A to D by High-Throughput Sequencing: Application for Viral Mixtures. Front. Microbiol.9, 2339 (2018). 10.3389/fmicb.2018.02339</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.02339</ArticleId><ArticleId IdType="pmc">PMC6172331</ArticleId><ArticleId IdType="pubmed">30323802</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, S. et al. A one-step, triplex, real-time RT-PCR assay for the simultaneous detection of enterovirus 71, coxsackie A16 and pan-enterovirus in a single tube. PLoS One9, e102724 (2014). 10.1371/journal.pone.0102724</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0102724</ArticleId><ArticleId IdType="pmc">PMC4100918</ArticleId><ArticleId IdType="pubmed">25029500</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste, M. S. et al. Typing of human enteroviruses by partial sequencing of VP1. J. Clin. Microbiol.37, 1288–1293 (1999). 10.1128/JCM.37.5.1288-1293.1999</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.37.5.1288-1293.1999</ArticleId><ArticleId IdType="pmc">PMC84754</ArticleId><ArticleId IdType="pubmed">10203472</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulholm, T. et al. Molecular typing of enteroviruses: comparing 5’UTR, VP1 and whole genome sequencing methods. Pathology54, 779–783 (2022). 10.1016/j.pathol.2022.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pathol.2022.03.013</ArticleId><ArticleId IdType="pubmed">35738943</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>